RDH12
protein-codingretinol dehydrogenase 12, the group of Short chain dehydrogenase/reductase superfamily
Gene summary
The protein encoded by this gene is an NADPH-dependent retinal reductase whose highest activity is toward 9-cis and all-trans-retinol. The encoded enzyme also plays a role in the metabolism of short-chain aldehydes but does not exhibit steroid dehydrogenase activity. Defects in this gene are a cause of Leber congenital amaurosis type 13 and Retinitis Pigmentosa 53. [provided by RefSeq, Sep 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~32.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0800099
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0800100
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012990
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0800100
Submitter: ClinGen
*RDH12*, the gene encoding retinol dehydrogenase 12, was first reported in relation to autosomal dominant retinitis pigmentosa in 2008 (Fingert et al., PMID: 18779497). RDH12-related dominant retinopathy is associated with late onset cases typically diagnosed as retinitis pigmentosa with a milder phenotype, characterized by nyctalopia and visual field loss, but relatively preserved central vision. Per criteria outlined by the ClinGen Lumping & Splitting Working Group, the difference in inheritance pattern and phenotypic variability between autosomal dominant and autosomal recessive cases led them to be split into separate disease entities. The split curation for RDH12-related recessive retinopathy has been performed separately. This curation includes three frameshift variants that have been reported in 4 probands in 3 publications (PMIDs: 18779497, 32322264, 34031043). The score for genetic evidence is 6.5 points. The mechanism of pathogenicity is reported to be gain-of-function, most likely due to the creation of an alternate reading frame predicted to escape NMD and lead to a truncated protein with altered C-terminus. This gene-disease association is also supported expression studies and *in vitro* functional assays (PMIDs: 12226107, 15865448). The RDH12 enzyme catalyzes the reduction of all-trans-retinal and its 9-cis-, 11-cis-, and 13-cis-retinal isomers in the presence of NADPH (PMID: 12226107). Human *RDH12* mRNA is most highly expressed in retinal tissues (PMID: 15865448). The experimental evidence score is 1.5 points. In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Retinal Gene Curation Expert Panel on March 3rd, 2022 (SOP Version 8).
Inheritance Pattern: AD
Disease ID:MONDO:0012990
Submitter: Natera
Inheritance Pattern: AD
Disease ID:MONDO:0012990
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0012990
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0800099
Submitter: ClinGen
RDH12, Retinol Dehydrogenase 12, was first reported in relation to RDH12-related recessive retinopathy in patient described with Leber congenital amaurosis, LCA, in 2004 (Janeke et al., PMID: 15258582). Variants in RDH12 cause early-onset retinal degeneration leading to vision loss with variable severity. To capture the overlapping spectrum of clinical presentations linked to this gene, it is curated under the disease entity “inherited retinal degeneration”. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found there to be a difference in inheritance pattern phenotypic variability. Therefore, the curation will be split into autosomal recessive inherited retinal degeneration, which includes cases described with autosomal recessive LCA (OMIM: 612712) and autosomal dominant inherited retinal degeneration, which will include autosomal dominant retinitis pigmentosa (OMIM: 268000). The split curation for autosomal dominant condition will be curated separately. Fifteen variants (12 missense, 2 nonsense, 1 frameshift) that have been reported in 11 probands in 2 publications (PMIDs: 15258582, 32014858) are included in this curation. [Additional essential genetic evidence description]. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be LOF. This gene-disease association is also supported animal models, expression studies and in vitro functional assays (PMIDs: 12226107, 16269441, 17032653). Haesseler et al (12226107) demonstrates that RDH12 enzyme catalyzed the reduction of all-trans-retinal and its 9-cis-, 11-cis-, and 13-cis-retinal isomers in the presence of NADPH. While Thompson et al. (16269441) shows expression of the transcript localizes to the inner segments of rod and cone photoreceptors. Genetic alterations in RDH12 result in significantly decreased enzymatic activity and reduced expression of the protein suggesting LOF. Finally, animal models show photoreceptor degeneration in RDH12 knockouts. In summary, there is definitive evidence to support the relationship between RDH12 and RDH12-related recessive retinopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Retinal GCEP on the meeting date March 3, 2022 (SOP Version 8).
Inheritance Pattern: AD
Disease ID:MONDO:0018998
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012990
Submitter: Natera
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to RDH12 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_152443.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 174 | 176 | |||
| missense | 11 | 73 | 201 | 2 | 287 | |
| nonsense | 13 | 11 | 1 | 25 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 22 | 22 | 1 | 45 | ||
| splice donor/acceptor (+/-2bp) | 10 | 15 | 3 | 28 | ||
| Total | 56 | 122 | 208 | 177 | 0 | 563 |
Highest pathogenic variant AF is 0.00018009928
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_689656.2 | 7 | MANE Select | |
| Ensembl | ENSP00000449079.1 | 7 | MANE Select | |
| Ensembl | ENSP00000267502.3 | 7 | Standard | |
| Ensembl | ENSP00000267502.3 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Retinol metabolism - Homo sapiens (human)
- Vitamin A Deficiency
- Retinol Metabolism
- Vitamin A and Carotenoid Metabolism
- Signaling by GPCR
Biological Process
- retinoid metabolic process
- visual perception
- retinol metabolic process
- photoreceptor cell maintenance
- response to stimulus
Molecular Function
- retinol dehydrogenase activity
- protein binding
- NADP-retinol dehydrogenase activity
Cellular Component
- photoreceptor inner segment membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000551171
- Coding exons
- 7
- Length
- 32567
- Individuals with no LoFs
- 125656
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 92
- Defined
- 125748
- p
- 0.000366
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.142 | 182 | 177 | 1.03 | 0.0000110 | 2018 |
| Missense (PolyPhen) | 86 | 78.487 | 1.0957 | 924 | ||
| Synonymous | -1.33 | 91 | 76.3 | 1.19 | 0.00000463 | 683 |
| Loss of Function | 0.292 | 14 | 15.2 | 0.919 | 0.00000113 | 156 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00043 | 0.00043 | rare |
| Latino/Admixed American | 0.00043 | 0.00043 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00055 | 0.00055 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Exhibits an oxidoreductive catalytic activity towards retinoids. Most efficient as an NADPH-dependent retinal reductase. Displays high activity toward 9-cis and all-trans-retinol. Also involved in the metabolism of short-chain aldehydes. No steroid dehydrogenase activity detected. Might be the key enzyme in the formation of 11-cis-retinal from 11-cis-retinol during regeneration of the cone visual pigments. {ECO:0000269|PubMed:12226107}.;
- Disease
- DISEASE: Retinitis pigmentosa 53 (RP53) [MIM:612712]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:19140180, ECO:0000269|PubMed:19956407}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.182
Intolerance Scores
- LoFtool
- 0.289
- RVIS EVS
- -0.65
- RVIS percentile EVS
- 16.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.896
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |